Free Trial

Nuveen LLC Buys Shares of 78,651 CompoSecure, Inc. $CMPO

CompoSecure logo with Business Services background

Nuveen LLC acquired a new position in shares of CompoSecure, Inc. (NASDAQ:CMPO - Free Report) in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 78,651 shares of the company's stock, valued at approximately $855,000. Nuveen LLC owned about 0.08% of CompoSecure as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. GAMMA Investing LLC boosted its position in CompoSecure by 1,524.4% in the 1st quarter. GAMMA Investing LLC now owns 2,794 shares of the company's stock valued at $30,000 after buying an additional 2,622 shares during the last quarter. MorganRosel Wealth Management LLC purchased a new position in CompoSecure in the 1st quarter valued at about $43,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in CompoSecure by 71.1% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,547 shares of the company's stock valued at $115,000 after buying an additional 4,384 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in CompoSecure by 11.2% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 11,339 shares of the company's stock valued at $123,000 after buying an additional 1,138 shares during the last quarter. Finally, Summit Trail Advisors LLC purchased a new position in CompoSecure in the 1st quarter valued at about $129,000. 37.56% of the stock is currently owned by institutional investors and hedge funds.

CompoSecure Trading Down 0.3%

NASDAQ CMPO traded down $0.06 during trading hours on Friday, reaching $18.50. The company's stock had a trading volume of 669,306 shares, compared to its average volume of 1,194,942. The business has a 50-day simple moving average of $16.34 and a 200 day simple moving average of $13.65. CompoSecure, Inc. has a 52 week low of $9.24 and a 52 week high of $20.14. The stock has a market cap of $1.89 billion, a PE ratio of -11.01 and a beta of 0.97.

Analyst Ratings Changes

A number of equities analysts have weighed in on CMPO shares. JPMorgan Chase & Co. reissued an "underweight" rating and issued a $16.00 price objective on shares of CompoSecure in a research report on Wednesday, August 20th. Wall Street Zen cut shares of CompoSecure from a "buy" rating to a "hold" rating in a research report on Thursday, May 22nd. B. Riley reissued a "buy" rating and issued a $23.00 price objective (up from $17.00) on shares of CompoSecure in a research report on Monday, August 18th. Needham & Company LLC reissued a "buy" rating and issued a $15.00 price objective on shares of CompoSecure in a research report on Tuesday, May 13th. Finally, Benchmark increased their price target on shares of CompoSecure from $14.00 to $17.00 and gave the stock a "buy" rating in a research report on Friday, August 8th. Five investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, CompoSecure currently has an average rating of "Moderate Buy" and a consensus target price of $17.67.

Check Out Our Latest Analysis on CompoSecure

Insider Buying and Selling at CompoSecure

In related news, COO Gregoire Maes sold 97,226 shares of the firm's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $19.36, for a total transaction of $1,882,295.36. Following the transaction, the chief operating officer owned 779,062 shares in the company, valued at $15,082,640.32. This trade represents a 11.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Rebecca Corbin Loree acquired 5,240 shares of the stock in a transaction that occurred on Friday, August 29th. The shares were bought at an average price of $19.09 per share, for a total transaction of $100,031.60. Following the purchase, the director directly owned 5,240 shares of the company's stock, valued at approximately $100,031.60. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders sold 217,125 shares of company stock worth $4,139,550. Insiders own 52.10% of the company's stock.

CompoSecure Company Profile

(Free Report)

CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.

Read More

Institutional Ownership by Quarter for CompoSecure (NASDAQ:CMPO)

Should You Invest $1,000 in CompoSecure Right Now?

Before you consider CompoSecure, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CompoSecure wasn't on the list.

While CompoSecure currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.